Comparison of clinical results between heparin surface modified hydrophilic acrylic and hydrophobic acrylic intraocular lens

European Journal of Ophthalmology

Volumn 18, Issue 3, 2008, Pages 377-383

  Kang, S ^a   Kim, M J ^b   Park, S H ^a   Joo, Choun Ki ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Heparin surface modified; Hydrophilic acrylic intraocular lens; Hydrophobic acrylic intraocular lens

Indexed keywords

ACRYLIC ACID; HEPARIN;

ADULT; AGED; ARTICLE; CAPSULOTOMY; CATARACT; CHEMICAL MODIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENDOPHTHALMITIS; EQUIPMENT DESIGN; EYE SYNECHIA; FEMALE; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; ILLUMINATION; INTRAOCULAR PRESSURE ABNORMALITY; LENS IMPLANT; LENS LUXATION; MAJOR CLINICAL STUDY; MALE; NEODYMIUM LASER; PHACOEMULSIFICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REFRACTION ERROR; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 54749093198     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210801800311     Document Type: Article

References (23)

1. Ohara K. Biomicroscopy of surface deposits resembling foreign-body giant cells on implanted intraocular lenses. Am J Ophthalmol 1985; 99: 304-11.
2. Sievers H, von Domarus D. Foreign-body reaction against intraocular lenses. Am J Ophthalmol 1984; 97: 743-51.
3. Shah SM, Spalton DJ. Comparison of the postoperative inflammatory response in the normal eye with heparin-surface modified and poly (methyl methacrylate) intraocular lenses. J Cataract Refract Surg 1995; 21: 579-85.
4. Ygge J, Wenzel M, Philipson B, Fagerholm P. Cellular reactions on heparin surface modified versus regular PMMA lenses during the first postoperative month. A double-masked and randomized study using specular microphotography. Ophthalmology 1990; 97: 1216-23.
5. Mester U, Strauss M, Grewing R. Biocompatibility and blood-aqueous barrier impairment in at-risk eyes with heparin-surface-modified or unmodified lenses. J Cataract Refract Surg 1998; 24: 380-4.
6. Percival SPC, Pai V. Heparin-modified lenses for eyes at risk for breakdown of the blood-aqueous barrier during cataract surgery. J Cataract Refract Surg 1993; 19: 760-5.
7. Lin CL, Wang AG, Chou JC, Shieh G, Liu JH. Heparin-surface-modified intraocular lens implantation in patients with glaucoma, diabetes, or uveitis. J Cataract Refract Surg 1994; 20: 550-3.
8. Trocme SD, Li H. Effect of heparin-surface-modified intraocular lenses on postoperative inflammation after phacoemulsification: a randomized trial in a United States patient population. Heparin-Surface-Modified Lens Study Group. Ophthalmology 2000; 107: 1031-7.
9. Andrea ME, Michael A, Jorg S, et al. Cellular reaction on the anterior surface of 4 types of intraocular lenses. J Cataract Refract Surg 2001; 27: 734-40.
10. Beltrame G, Salvetat ML, Chizzolini M. Posterior capsule opacification and Nd: YAG capsulotomy rates after implantation of silicone, hydrogel and soft acrylic intraocular lenses: a two-year follow-up study. Eur J Ophthalmol 2002; 12: 388-94.
11. Hollick EJ, Spalton DJ, Ursell PG, et al. The effect of polymethylmethacrylate, silicone, and polyacrylic intraocular lenses on posterior capsular opacification 3 years after cataract surgery. Ophthalmology 1999; 106: 49-54.
12. Tognetto D, Toto L, Minutola D, et al. Hydrophobic acrylic versus heparin surface-modified polymethylmethacrylate intraocular lens: a biocompatibility study. Graefes Arch Clin Exp Ophthalmol 2003; 204: 625-30.
13. Bender L, Spalton DJ, Uyanonvara B, et al. POCOman: new system for quantifying posterior capsule opacification. J Cataract Refract Surg 2004; 30: 2058-63.
14. Oshika T, Suzuki Y, Kizaki H, Yaguchi S. Two year clinical study of a soft acrylic intraocular lens. J Cataract Refract Surg 1996; 22: 104-9.
15. Jeon EJ, Kim KB, Yang SW. Clinical results in 1000 cases of Acrysof intraocular lens implantations. J Korean Ophthalmol Soc 2000; 41: 1151-7.
16. Nishi O, Nishi K, Sakanishi K. Inhibition of migrating lens epithelial cells at the capsular bend created by the rectangular optic edge of a posterior chamber intraocular lens. Ophthalmic Surg Lasers 1998; 29: 587-94.
17. Ursell PG, Spalton DJ, Pande MV, et al. Relationship between intraocular lens biomaterials and posterior capsule opacification. J Cataract Refract Surg 1998; 24: 352-60.
18. Nagata T, Minakata A, Watanabe I. Adhesiveness of AcrySof to a collagen film. J Cataract Refract Surg 1998; 24: 367-70.
19. Del Vecchio PJ, Bizios R, Holleran LA, Judge TK, Pinto GL. Inhibition of human scleral fibroblast proliferation with heparin. Invest Ophthalmol Vis Sci 1988; 29: 1272-6.
20. Tognetto D, Ravalico G. Inflammatory cell adhesion and surface defects on heparin-surface-modified poly (methyl methacrylate) intraocular lenses in diabetic patients. J Cataract Refract Surg 2001; 27: 239-44.
21. Xie L, Sun J, Yao Z. Heparin drug delivery system for prevention of posterior capsular opacification in rabbit eyes. Graefes Arch Clin Exp Ophthalmol 2003; 241: 309-13.
22. Lee DH, Seo Y, Joo CK. Progressive opacification of hydrophilic acrylic intraocular lenses in diabetic patients. J Cataract Refract Surg 2002; 28: 1271-5.
23. Schild G, Schauersberger J, Amon M, et al. Lens epithelial cell ongrowth: comparison of 6 types of hydrophilic intraocular lens models. J Cataract Refract Surg 2005; 31: 2375-8.